| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.01M | - | |
| Dir | 4.52M | $14.29M | - | |
| CEO | 2.26M | $7.15M | - | |
| Dir | 1.24M | $3.92M | - | |
| Other | 1.11M | $3.50M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 6,300 | $7.95 | $50,059.80 | - | -32.8% | +31.1% | |
| Feb 13, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 32,474 | $7.97 | $258,837.26 | +0.3% | -29.8% | +22.7% | |
| Feb 10, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 11,000 | $7.98 | $87,807.50 | - | -34.1% | +23.2% | |
| Feb 7, 2023 | Borgeson Blake69 | Director | Sell | 8,885 | $8.81 | $78,262.63 | -0.1% | -36.8% | +3.0% | |
| Feb 2, 2023 | Gibson Christopher70 | Chief Executive Officer | Sell | 21,000 | $9.22 | $193,561.10 | -2.2% | -44.9% | -0.9% | |
| Feb 1, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 600 | $7.97 | $4,782.00 | - | -46.7% | +11.7% | |
| Jan 26, 2023 | Larson Tina Marriott73 | President And COO | Sale+OE | 8,000 | $8.07 | $64,547.20 | -3.8% | -39.3% | +19.4% | |
| Jan 26, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 7,886 | $7.99 | $63,005.99 | - | -39.3% | +19.4% | |
| Jan 25, 2023 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 24,526 | $7.88 | $193,267.33 | +0.2% | -37.1% | +24.5% | |
| Jan 24, 2023 | Borgeson Blake69 | Director | Sell | 8,885 | $8.71 | $77,367.91 | -0.1% | -37.1% | +20.6% |